OOIR: Observatory of International Research

Papers

(The H4-Index of Microbes and Infection is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-10-01 to 2023-10-01.)

Article	Citations
Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses	505
Is COVID-19 receiving ADE from other coronaviruses?	314
The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future	236
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China	234
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2	143
Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes	129
Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster	129
Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses	121
Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses	100
A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients	93
The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement	89
Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study	89
Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency	80
Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases	76
Arbidol/IFN-α2b therapy for patients with corona virus disease 2019: a retrospective multicenter cohort study	66
Could nasal nitric oxide help to mitigate the severity of COVID-19?	65
Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season	60
Molecular basis of COVID-19 relationships in different species: a one health perspective	52
Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis	49
Zika virus infection: an update	47
Bacterial and fungal co-infections among COVID-19 patients in intensive care unit	42
Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19	39
Anti-science extremism in America: escalating and globalizing	38
COVID19 meets the antivaccine movement	37
Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China	37

Current development of COVID-19 diagnostics, vaccines and therapeutics	35
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development	35
Beneficial microbiota. Probiotics and pharmaceutical products in functional nutrition and medicine	34
Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants	33